Literature DB >> 11882032

IL-1ra and IL-1 production in human oral mucosal epithelial cells in culture: differential modulation by TGF-beta1 and IL-4.

S Perrier1, B Kherratia, C Deschaumes, S Ughetto, J-L Kemeny, M Baudet-Pommel, B Sauvezie.   

Abstract

Regulatory cytokines mediate the participation of oral mucosal epithelial cells (OMEC) in local immune responses. The aim of this study was to characterize the isoforms of IL-1 receptor antagonist (IL-1ra) in cultured human primary OMECs and to compare its production with that of IL-1 alpha (IL-1alpha) and IL-1 beta (IL-1beta). Western blot analysis showed that IL-1ra was 22 kDa in size hence slightly smaller than monocyte IL-1ra (25 kDa). A minor form of 20 kDa was also found in unstimulated cell culture lysates. In culture supernatants, IL-1 bioactivity increased after IL-1ra neutralization, indicating that the baseline production of IL-1ra is biologically relevant. Immunohistochemistry showed a relation between IL-1ra and involucrin expressions, suggesting that intracytoplasmic IL-1ra may be involved in cell terminal differentiation. In unstimulated culture lysates, there was far more IL-1ra than IL-1alpha and IL-1beta. TGF-beta1 markedly increased the IL-1ra/IL-1beta ratio from 93.6 : 1 to 300 : 1. IL-4, which is generally described as an anti-inflammatory cytokine, increased IL-1 but not IL-1ra production. TNF-alpha increased intracellular production of the three IL-1 members. IL-1ra levels were lower in supernatants than in lysates of cultured cells. Our results show that human OMECs constitutively produce significant amounts of a biologically active form of IL-1ra. TGF-beta1 mu(p)-regulation points to a positive amplification loop and IL-4 to a down-regulation loop, both including Th2 cells and OMECs. They may be important in oral tolerance and IgA production, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882032      PMCID: PMC1906287          DOI: 10.1046/j.1365-2249.2002.01685.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Interleukin-1 receptor antagonist and interleukin-4 in gingival crevicular fluid of patients with inflammatory periodontal disease.

Authors:  H Kabashima; K Nagata; I Hashiguchi; Y Toriya; T Iijima; K Maki; K Maeda
Journal:  J Oral Pathol Med       Date:  1996-09       Impact factor: 4.253

2.  Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenella corrodens.

Authors:  H Yumoto; H Nakae; K Fujinaka; S Ebisu; T Matsuo
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

4.  A mucosal intranet: intestinal epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes.

Authors:  M Yamamoto; K Fujihashi; K Kawabata; J R McGhee; H Kiyono
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

5.  Cytokine expression of human oral keratinocytes.

Authors:  M Formanek; B Knerer; J Kornfehl
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1999 Mar-Apr       Impact factor: 1.538

6.  The fine structure of epithelial cells in normal and pathological buccal mucosa. IV. Interactions between epithelial cells, lymphocytes, and macrophages.

Authors:  C J Griffin
Journal:  Aust Dent J       Date:  1980-10       Impact factor: 2.291

7.  Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-beta and phospholipase C-gamma 1 levels and apoptotic cell death.

Authors:  B M Min; K M Woo; G Lee; N H Park
Journal:  Exp Cell Res       Date:  1999-06-15       Impact factor: 3.905

8.  Chemokine expression in human oral keratinocyte cell lines and keratinized mucosa.

Authors:  M Bickel; S M Nöthen; K Freiburghaus; D Shire
Journal:  J Dent Res       Date:  1996-11       Impact factor: 6.116

9.  IL-1 receptor antagonist in saliva; characterization in normal saliva and reduced concentration in Sjögren's syndrome (SS).

Authors:  J J Dubost; S Perrier; M Afane; J L Viallard; P Roux-Lombard; M Baudet-Pommel; C Begue; J L Kemeny; B Sauvezie
Journal:  Clin Exp Immunol       Date:  1996-11       Impact factor: 4.330

10.  Oral keratinocytes derived from the peritonsillar mucosa express the proinflammatory cytokine IL-6 without prior stimulation.

Authors:  M Formanek; B Knerer; A Temmel; D Thurnher; W Millesi; J Kornfehl
Journal:  J Oral Pathol Med       Date:  1998-05       Impact factor: 4.253

View more
  4 in total

1.  Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.

Authors:  Richard A Johnston; Joseph P Mizgerd; Lesley Flynt; Lee J Quinton; Erin S Williams; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

2.  Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells.

Authors:  Lyndsey R Buckner; Maria E Lewis; Sheila J Greene; Timothy P Foster; Alison J Quayle
Journal:  Cytokine       Date:  2013-05-11       Impact factor: 3.861

3.  An in vitro intestinal model captures immunomodulatory properties of the microbiota in inflammation.

Authors:  Jaclyn Y Lock; Mariaelena Caboni; Philip Strandwitz; Madeleine Morrissette; Kevin DiBona; Brian A Joughin; Kim Lewis; Rebecca L Carrier
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 4.  IL-1/IL-1R Signaling in Head and Neck Cancer.

Authors:  Sven E Niklander; Craig Murdoch; Keith D Hunter
Journal:  Front Oral Health       Date:  2021-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.